BioNTech SE (BNTX) Cash from Financing Activities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Cash from Financing Activities data on file, last reported at -$16.6 million in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities fell 113.39% year-over-year to -$16.6 million; the trailing twelve-month figure through Dec 2025 stood at -$59.7 million (down 20.26% YoY), and the FY2025 full-year result was -$59.8 million, down 21.85% from the prior year.
• Cash from Financing Activities fell to -$16.6 million in Q4 2025, from -$13.4 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $184.1 million in Q2 2021 to a low of -$833.9 million in Q2 2022.
• A 5-year average of -$112.2 million and a median of -$14.2 million in 2023 frame the typical range for Cash from Financing Activities.
• Peak annual rise in Cash from Financing Activities reached 1660329323.39% in 2022, while the deepest fall reached 118001159.55% in 2022.
• Tracing BNTX's Cash from Financing Activities over 5 years: stood at $55.94 in 2021, then tumbled by 118001159.55% to -$66.0 million in 2022, then surged by 78.97% to -$13.9 million in 2023, then soared by 43.8% to -$7.8 million in 2024, then slumped by 113.39% to -$16.6 million in 2025.
• Business Quant data shows BNTX's Cash from Financing Activities at -$16.6 million in Q4 2025, -$13.4 million in Q3 2025, and -$15.1 million in Q2 2025.